Rowley Law PLLC is investigating potential securities law violations by Neos Therapeutics Inc (NASDAQ: NEOS) and its board of directors concerning the proposed acquisition of the company by Aytu BioScience Inc (NASDAQ: AYTU) Stockholders will receive 01088 shares of Aytu BioScience common stock for each share of Neos Therapeutics stock that they hold The transaction is valued at approximately $449 million and is expected to close by the second quarter of 2021

If you are a stockholder of Neos Therapeutics Inc and are interested in obtaining additional information regarding this investigation please visit us at: http://wwwrowleylawpllccom/investigation/neos/ You may also contact Shane Rowley Esq at Rowley Law PLLC 50 Main Street Suite 1000 White Plains NY 10606 by email at [email protected] or by telephone at 914-400-1920 or 844-400-4643 (toll-free)  

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation For more information about the firm and its attorneys please visit http://wwwrowleylawpllccom 

Attorney Advertising Prior results do not guarantee a similar outcome